Wells Fargo & Company Issues Positive Forecast for Omega Healthcare Investors (NYSE:OHI) Stock Price

Posted by Francis Steltz on Jun 1st, 2026

Omega Healthcare Investors (NYSE:OHI – Get Free Report) had its price target upped by equities research analysts at Wells Fargo & Company from $47.00 to $49.00 in a research report issued on Monday,Benzinga reports. The brokerage currently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s price objective would suggest a potential upside of 6.17% from the stock’s previous close.

Other analysts also recently issued reports about the company. BMO Capital Markets reaffirmed a “market perform” rating and set a $52.00 price target on shares of Omega Healthcare Investors in a research report on Monday, May 4th. Weiss Ratings raised Omega Healthcare Investors from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Tuesday, April 21st. Cantor Fitzgerald raised their target price on Omega Healthcare Investors from $50.00 to $52.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 10th. Scotiabank raised their target price on Omega Healthcare Investors from $48.00 to $50.00 and gave the stock a “sector perform” rating in a research report on Thursday, May 21st. Finally, Bank of America reissued an “underperform” rating and issued a $46.00 target price (down from $52.00) on shares of Omega Healthcare Investors in a research report on Tuesday, April 14th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $49.17.

Get Our Latest Analysis on OHI

Omega Healthcare Investors Stock Down 1.3%

Shares of OHI stock traded down $0.61 during trading hours on Monday, reaching $46.15. The company had a trading volume of 345,982 shares, compared to its average volume of 2,078,392. The company has a debt-to-equity ratio of 0.81, a current ratio of 5.32 and a quick ratio of 5.32. The company has a market cap of $13.74 billion, a price-to-earnings ratio of 22.29, a price-to-earnings-growth ratio of 2.01 and a beta of 0.58. The business has a fifty day simple moving average of $46.35 and a 200-day simple moving average of $45.70. Omega Healthcare Investors has a 12 month low of $35.70 and a 12 month high of $49.33.

Omega Healthcare Investors (NYSE:OHI – Get Free Report) last issued its quarterly earnings results on Tuesday, April 28th. The real estate investment trust reported $0.47 EPS for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.02). The business had revenue of $322.96 million for the quarter, compared to analysts’ expectations of $264.07 million. Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. The business’s revenue was up 16.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.75 earnings per share. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. On average, research analysts expect that Omega Healthcare Investors will post 3.07 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of OHI. Norges Bank purchased a new position in Omega Healthcare Investors during the 4th quarter valued at about $156,166,000. Invesco Ltd. increased its holdings in Omega Healthcare Investors by 101.7% during the 3rd quarter. Invesco Ltd. now owns 4,944,921 shares of the real estate investment trust’s stock valued at $208,775,000 after purchasing an additional 2,493,877 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in Omega Healthcare Investors during the 4th quarter valued at about $93,476,000. Cbre Investment Management Listed Real Assets LLC grew its holdings in shares of Omega Healthcare Investors by 327.5% during the 4th quarter. Cbre Investment Management Listed Real Assets LLC now owns 2,222,799 shares of the real estate investment trust’s stock worth $98,559,000 after acquiring an additional 1,702,846 shares during the period. Finally, JPMorgan Chase & Co. grew its holdings in shares of Omega Healthcare Investors by 77.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,417,240 shares of the real estate investment trust’s stock worth $144,278,000 after acquiring an additional 1,496,059 shares during the period. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

(Get Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.